Skip to main content
. Author manuscript; available in PMC: 2016 Feb 26.
Published in final edited form as: Bone Marrow Transplant. 2014 Jun 2;49(8):1029–1035. doi: 10.1038/bmt.2014.116

Table 2.

Management at Relapse

Total N=104
n (%)
RD N=32
n (%)
UCB N=72
n (%)
P-value

Withdrawal of IST* .51
Yes 57 (75) 16 (67) 41 (79)
No 2 (3) 1 (4) 1 (2)
Unknown 17 (22) 7 (29) 10 (19)

Treatment at relapse < .01
Intensive
  Chemotherapy 29 (28) 7 (22) 22 (31)
  DLI 12 (12) 12 (38) 0 (0)
  2nd AlloHCT 11 (11) 2 (6) 9 (13)
Supportive 37 (34) 7 (22) 30 (42)
Unknown 15 (14) 4 (13) 11 (15)

Abbreviations: IST, immunosuppressive therapy

*

At relapse only 76 patients have been receiving IST